EGMCF Stock UPDATES Emgold Mining Corp (EGMCF) 0.0230 08/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Emgold Mining Corp (EGMCF) 0.0230 $EGMCF

Emgold Completes Acquisition Buckskin Rawhide East Property, Nevada
ACCESSWIRE - Mon Jul 28, 8:16AM CDT
Vancouver, BC / ACCESSWIRE / July 28 2014 / Emgold Mining Corporation / ("Emgold" or the "Company" is pleased to announce that it has completed the acquisition of 100% of the Buckskin Rawhide East Property (the "Property" . The Property is located in the Rawhide Mining District, about 40 miles southeast of Fallon, Nevada. It consists of 52 unpatented mineral lode claims totaling approximately 835 acres. Gold and silver mineralization occurs throughout the property which was sampled and drilled historically by Kennecott Minerals Company ("Kennecott" and others. The Property is surrounded by Rawhide Mining LLC's ("RMC" operating Denton-Rawhide Mine and Regent Property.

Emgold Closes CDN US$250,000 Private Placement
ACCESSWIRE - Fri Jul 18, 8:31AM CDT
Vancouver, BC / ACCESSWIRE / July 18 2014 / Emgold Mining Corporation (the "Company" or "Emgold" has closed Tranche 3 of a previously announced private placement (see July 11, 2014 press release) for gross proceeds of CDN$250,000. The private placement involves the issuance of 5,000,000 units ("Units" to Rawhide Mining LLC at a price of CDN$0.05 per Unit. The private placement is the third and final tranche of a CDN$1.0 million private placement that is part of a series of transactions related to the Company's Buckskin Rawhide East Property. Each Unit consists of one common share (a "Share" of the Company and one half of one non-transferable share purchase warrant (each full warrant, a "Warrant" . Each Warrant entitles RMC to purchase, for a period of 24 months, one additional Share at a price of CDN$0.10. The Shares and any Shares issuable on the exercise of Warrants, are subject to a minimum hold period of four months plus one day, expiring November 19, 2014. No finder's fees were paid as part of this private placement.

Emgold Announces CDN $250,000 Non-Brokered Private Placement
ACCESSWIRE - Fri Jul 11, 8:35AM CDT
Vancouver, BC / ACCESSWIRE / July 11 2014 / Emgold Mining Corporation ("Emgold" or the "Company" announces that it intends to conduct a non-brokered private placement to raise gross proceeds of CDN$250,000. This private placement is the third and final tranche of a previously announced CDN $1,000,000 financing with Rawhide Mining LLC ("RMC" , as outlined in November 14, 19, 26, and December 28, 2012 and January 30, 2013 press releases. The proceeds from this financing will be used to acquire the remaining 25% interest in the Buckskin Rawhide East Property (the "Property" in Nevada and for general working capital. Upon transfer of title, Emgold will obtain a 100% interest in the Property and subsequently lease the Property to RMC.

Emgold Provides Properties Update and Closes CDN $285,000 Private Placement
Marketwire - Fri Feb 01, 2:31PM CST
Emgold Mining Corporation (the "Company" or "Emgold" (TSX VENTURE: EMR)(OTCQB: EGMCF)(FRANKFURT: EML) provides the following update on its exploration and development properties and its recently announced private placement:

Emgold Intersects Gold At Its Rozan Property, B.C.
Marketwire - Mon Jan 28, 8:03AM CST
Emgold Mining Corporation ("Emgold" or the "Company" (TSX VENTURE: EMR)(OTCQB: EGMCF)(FRANKFURT: EML) is pleased to announce successful completion of its 2012 field exploration program at its Rozan Property (the "Property" . The Rozan Property is an early stage poly-metallic exploration project located in the Nelson Mining District, approximately 10 kilometers southwest of Nelson, British Columbia. William Rozan staked the area in 1928 and operated a small scale high grade gold mining operation on the Property until the early 1970's. The Rozan Property consists of 32 mineral claims covering an area of 1,950 hectares.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 135

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 318

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 269

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 283

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 406

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 180

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 103

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 235

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

Sandler Partners Unveils 2025 Superstar Trip Destination

Updated Category News Views 179

Sandler Partners Unveils 2025 Superstar Trip Destination Sandler Partners is thrilled to reveal the highly anticipated location for its 2025 Superstar Trip, a special reward designed to honor Partners who have excelled in achieving their growth objectives for the year. The trip will take place at the stunning Susurros del Corazón Resort, located along the picturesque...

Continue Reading
e.l.f. Beauty Stock Insights: Understanding Market Trends Today

Updated Category News Views 309

Market Sentiment Surrounding e.l.f. Beauty Investors with substantial capital are showing a cautious approach towards e.l.f. Beauty (NYSE: ELF). This sentiment isn't just noise in the market; it reflects deeper strategies that should be on the radar of traders and analysts alike. There has been significant insight gleaned from public options activity which suggests that...

Continue Reading
Empowering Teens Through Free AI Bootcamp by Mark Cuban

Updated Category News Views 216

Empowering Teens Through Innovative AI Bootcamp Time is of the essence for high school students eager to launch their careers in technology with the Mark Cuban Foundation's Artificial Intelligence (AI) Bootcamp. Hosted by Girls Inc., this remarkable initiative opens doors for teens interested in the cutting-edge realm of AI. Applications for participation are set to close...

Continue Reading
BlackRock's Major Acquisition of Global Infrastructure Partners

Updated Category News Views 275

BlackRock Secures $12.5 Billion Deal The U.S. Federal Energy Regulatory Commission has recently approved BlackRock's substantial acquisition of Global Infrastructure Partners, valued at $12.5 billion. This approval is a pivotal moment for BlackRock as it seeks to broaden its reach within the infrastructure investment sector. Details of the Acquisition In this significant...

Continue Reading
Key Analyst Initiations Impacting Major Stocks This Week

Updated Category News Views 120

Recent Analyst Initiations: An Overview In the dynamic realm of stock trading, the insights of analysts can have a major impact on market trends. Recently, Wall Street has made significant adjustments to their ratings for several well-known stocks. Below, we summarize the latest analyst actions that may affect investor decisions this week. Arm Holdings plc (NASDAQ: ARM)...

Continue Reading